Stock Events

CRISPR THERAPEUTICS CRISPR THERAPEUTICS ORD SHS (0VRQ.LSE) Q3 2024 Earnings

0VRQ.LSE -0.29%
5AugConfirmed
Q2 2024
Q3 2024
-1.49
-1.45
-1.4
-1.36

Details

Expected EPS
-1.427466
Actual EPS
-1.49
Surprise EPS
-0.06
Surprise Percent
+4.38%

Description

CRISPR THERAPEUTICS CRISPR THERAPEUTICS ORD SHS (0VRQ.LSE) has reported earnings of -1.49 per share for Q3 2024.

0 Comments

Share your thoughts